Skinvisible (SKVI) Accumulated Expenses (2010 - 2026)

Skinvisible (SKVI) has 17 years of Accumulated Expenses data on file, last reported at $3.5 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 19.56% year-over-year to $3.5 million; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (up 19.56% YoY), and the FY2025 full-year result was $3.4 million, up 20.55% from the prior year.
• Accumulated Expenses rose to $3.5 million in Q1 2026, from $3.4 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $3.5 million in Q1 2026 to a low of $1.6 million in Q1 2022.
• A 5-year average of $2.6 million and a median of $2.6 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses soared 42.46% in 2022 and advanced 6.83% in 2025, its largest moves.
• Tracing SKVI's Accumulated Expenses over 5 years: stood at $2.0 million in 2022, then jumped by 31.69% to $2.6 million in 2023, then advanced by 8.13% to $2.8 million in 2024, then climbed by 20.55% to $3.4 million in 2025, then advanced by 4.21% to $3.5 million in 2026.
• Business Quant data shows SKVI's Accumulated Expenses at $3.5 million in Q1 2026, $3.4 million in Q4 2025, and $3.2 million in Q3 2025.